Skip To Content

ACD/Labs Blog

Sherry Myles
New generation of software brings higher productivity and efficiency to analytical laboratories, while adding complete, accessible, and re-usable analytical characterization to the modern informatics environment. Toronto, Canada (March 12, 2012)—Advanced Chemistry Development, Inc., (ACD/Labs) is pleased to announce the impending release of the initial lineup of ACD/Labs Spectrus Workbooks, the next element of the ACD/Spectrus...

Sherry Myles
ACD/NMR Workbook lets users interpret and assign 1D and 2D NMR spectra simultaneously with NMRSync Technology. Toronto, Canada (January 14, 2009)—ACD/Labs is set to release a new product, ACD/NMR Workbook with NMRSync Technology, that drastically reduces the time required to interpret and assign 1D and 2D NMR data. Available with ACD/Labs Version 12, NMR Workbook...

Sherry Myles
Toronto, CA (December 1, 2008)—Advanced Chemistry Development, Inc., (ACD/Labs) has released its latest version of specialized software for the pharmaceutical, biotech, and chemical industries. ACD/Labs Version 12 includes new features and capabilities developed in response to the needs of the industry and our customers. View the full list of new features and products at www.acdlabs.com/whatsnew/....

Sherry Myles
ASDI Deploys ACD/1D NMR Assistant to Synthetic Chemists Based on Previous Success with Automated Structure Verification Software Toronto, Canada (May 27, 2008) —ASDI, Inc., a leader in providing materials management services for the pharmaceutical and biotechnology industries, recently implemented a suite of NMR software tools from ACD/Labs for use by their Synthetic Chemistry Team. The new software is expected...

Sherry Myles
Drug manufacturer deploys suite of NMR tools at sites in France, Hungary, and Germany. Toronto, CA (April 15, 2008)—Advanced Chemistry Development, Inc., (ACD/Labs), an industry leader in the development of software for NMR processing, prediction, and data management, recently sold a suite of NMR software to one of the world’s leading pharmaceutical companies, Sanofi-Aventis, for use by five of...